Wird geladen...
Duration of natalizumab therapy and reasons for discontinuation in a multiple sclerosis population
OBJECTIVE: To determine multiple sclerosis patient characteristics that predict a shorter duration of natalizumab treatment. METHODS: The Tysabri Outreach: Unified Commitment to Health database was reviewed to identify patients treated with natalizumab at our centers. Cox proportional hazards models...
Gespeichert in:
| Veröffentlicht in: | Mult Scler J Exp Transl Clin |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6987494/ https://ncbi.nlm.nih.gov/pubmed/32064117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2055217320902488 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|